Anlon Healthcare incorporates 65 percent subsidiary Anlon Biologics
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
ANLON HEALTHCARE has incorporated a new subsidiary called ANLON BIOLOGICS PRIVATE LIMITED on July 10, 2026. Anlon Healthcare holds a 65 percent stake, subscribing to 65,000 equity shares of Rs 10 each for a total cash investment of Rs 6.5 lakh. The new subsidiary will develop and manufacture peptides, biosimilars and biological products, expanding Anlon's pain management portfolio into the biologics segment. The subsidiary has authorized and paid-up share capital of Rs 10 lakh each and is yet to commence operations, so turnover is nil.
Strategic entry into biologics and biosimilars segment expands future growth opportunities. Near-term financial impact is limited as the subsidiary is newly formed with nil revenue.